NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Debut

Debut

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.debutbiotech.com/

Last Round

VC Round

Aug 26, 2025

Total Funding Raised

$105.3M

Company Overview

Debut is a biotechnology company that develops advanced cell-free biomanufacturing platforms and AI-driven discovery tools to produce sustainable, high-performance bioactive ingredients for the cosmetics and skincare industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

cell-free biomanufacturingbiotech ingredientslab-grown ingredientsAI ingredient discoverysynthetic biologybio-identical ingredientscosmetic R&Dcontract manufacturingsustainable beautyingredient innovationbiotechsynbioclean beautybiotech platformcustom formulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Debut Comps

Public and private peers based on sector, stage, and business model.

Debut comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Debut Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 26, 2025
Series BOct 19, 2023
Series BJun 12, 2023
Series AAug 12, 2021
SeedJan 7, 2020

Key People

Founding team and executive leadership

Joshua Britton

Chief Executive Officer

Executive Team

Debut Investors

Notable investors and investment history

Debut investors
InvestorRounds
Better VenturesSeed
Fine Structure VenturesSeries A, Series B, VC Round
FTW VenturesSeed
Cultivian Sandbox VenturesSeries A, Series B
GS FuturesSeries B, VC Round
Cantos VenturesSeries A
Cavallo VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 12, 2026

    Derek Wanner appointed as new Chief Commercial Officer.

  • Jul 1, 2025

    Launched a plant cell biotechnology platform for fragrance ingredients.

Debut Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Debut Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Debut's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range96
Year Founded2019
Last FundingAug 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.